Skip to main content


The National Institutes of Health (NIH) campuses host a variety of events that inform, challenge, and unite the biomedical research community. IRP investigators lead or participate in many of these events, and they regularly present their work at scientific conferences at the NIH and around the world. We invite you to learn about (and possibly join us in) some of our upcoming events. Unless otherwise noted, times listed are Eastern Standard Time (EST).

Thursday, September 8, 2016 to Friday, September 9, 2016

Room 620/630, Bldg 35, NIH Bethesda Campus

Join us for the 4th NCI-Pancreatic Cancer Symposium. This year’s theme is “Current Advances and Future Challenges in Research and Treatment.” Pancreatic cancer remains one of the most lethal malignancies, and is expected to be the second leading cause of death due to cancer by 2020 in the United States. Recent progress in the basic and translational research has identified molecular subgroups, critical pathways associated with disease aggressiveness and novel molecular targets that could be harnessed in improving survival in patients with pancreatic cancer. This symposium presents recent advances in our understanding of the development, progression, early detection and treatment of pancreatic cancer, and would provide an exciting forum to discuss the current advances and challenges in improving diagnosis, prevention and treatment of this lethal malignancy. Registration is free but seating is limited, so please register.

Wednesday, September 21, 2016, 3:00 pm to 4:00 pm (reception to follow)

Masur Auditorium, NIH Clinical Center (Bldg 10) 

The 2016–2017 Wednesday Afternoon Lecture Series resumes with “Ancient DNA and the new science of the human past” by David Reich, Ph.D., Department of Microbiology and Molecular Genetics, Harvard Medical School. David Reich is interested in interested in human history and its relationship to biology. His lab takes advantage of the revolution in gene sequencing that has occurred in the last decade, along with new technology to sequence DNA extracted from ancient bones. The historical perspective that he brings to genetic data has led to a number of new insights about human biology and disease. The laboratory focuses on three areas, all of which capitalize on the historical perspective to learn about human biology: Using the Historical Perspective to Improve Human Health; A New History and Geography of Human Genes Informed by Ancient DNA; and The Effect of Population Mixture on Human Biology.

The NIH Director's Wednesday Afternoon Lecture Series, colloquially known as WALS, is the highest-profile lecture program at the NIH. Lectures occur on most Wednesdays from September through June from 3:00 to 4:00 p.m. in Masur Auditorium, Building 10 on the NIH Bethesda campus. Each season includes some of the biggest names in biomedical and behavioral research. The goal of the WALS is to keep NIH researchers abreast of the latest and most important research in the United States and beyond. An added treat is the annual J. Edward Rall Cultural Lecture, which features top authors and other cultural icons. All speakers are nominated by the NIH community. Refer to for the full 2016–2017 schedule (to be posted by the end of August).

Thursday, September 22, 2016 to Friday, September 23, 2016

Bethesda North Marriott and Conference Center, 5701 Marinelli Road, North Bethesda, Maryland

Zika Virus (ZIKV) is a growing, global epidemic. ZIKV has been associated with numerous birth and developmental defects, such as microcephaly, and other pregnancy and birth-related problems, including miscarriages, stillbirths, and other in utero complications. Because of these health issues, it is imperative that the scientific community understand the effects of ZIKV on pregnancy and pregnancy outcomes. The purpose of this workshop is to identify optimal approaches for treating and caring for the generation of children exposed to ZIKV in the womb.

This workshop is co-sponsored by the NICHD and the Office of Research on Women’s Health (ORWH). The objectives are to:

  • Develop a clinical and research strategy on how to appropriately  assess, evaluate, and monitor the neonate/infant/child affected by ZIKV in utero
  • Describe the available complications of in utero ZIKV exposure and infection
  • Use available information from other vertically transmitted pathogens to provide recommendations for assessment, evaluation, and management
  • Outline the research needs for treatment and rehabilitation approaches that optimize cognitive and physical function for Zika-affected children; and
  • Evaluate and expand on treatment options currently offered, such as intensive physical therapy and immersion therapies, role of parents and caregivers in treatments, including the evidence base for these therapies and current research gaps.

To register, visit If you require a sign language interpreters and/or reasonable accommodations to participate, please contact Christine Rogers (301-402-2205 or or the Federal TTY Relay Number (1-800-877-8339). Please make your requests at least 5 days in advance of the event.

For logistical questions, contact: Carly Sullivan at Palladian Partners, Inc. (Tel: 301-273-2817; Email: For content or meeting questions, contact: Bill Kapogiannis, Maternal and Pediatric Infectious Disease Branch, Division of Extramural Research, NICHD (Email:

Thursday, September 22, 2016 to Friday, September 23, 2016

Room 620-630, Porter Neuroscience Research Center (Bldg 35)

The discovery and characterization of P-glycoprotein as a mechanism of multidrug resistance is widely accepted as a seminal contribution to the ongoing effort to end death and alleviate suffering caused by cancer.  In honor of the 30th anniversary of the cloning of the human MDR1 (ABCB1) gene, we are planning a day-and-a-half scientific symposium. This event will include current and former members of the MDR group in the Laboratory of Cell Biology, as well as collaborators and colleagues in the field. More than 20 speakers are now confirmed. For more information, contact George Leiman,

Friday, September 23, 2016, 2:00 pm to 6:00 pm

Room 620-630, Bldg 35

Please join your colleagues for a special scientific symposium and salute to Win Arias, NIH Scientist Emeritus, titled “Bridging Basic Science and Liver Disease”. 

Scientific speakers include:

– Lewis Cantley, Cancer Center of Weill-Cornell Medical College, “PI-3-kinase and cancer metabolism”

– Daniel Jay, Tufts School of Medicine, “Extracellular Hsp90: a hub for activating the cancer invasive niche”

– Lola Reid, University of North Carolina School of Medicine, “Biliary tree stem/progenitors give rise to liver and pancreas”

– David Shafritz, Albert Einstein College of Medicine, “Hepatocyte Transplantation: a future therapeutic option?”

– Lawrence Gartner, University of Chicago School of Medicine, “A Strange Looking Baby, an MD/PhD Student and Peroxisomes”

– Allan Wolkoff, Albert Einstein College of Medicine, “Transporter trafficking through the hepatocyte: microtubules, motors, and accessory proteins”

– Jennifer Lippincott-Schwartz, Janelia Farms, HHMI, “Exploring intracellular dynamics with super-resolution microscopy”

Thursday, September 29, 2016 to Friday, September 30, 2016

Masur Auditorium, NIH Clinical Center (Bldg 10)

The NCI Center of Excellence in Immunology is a two-day national symposium, “From Metchnikoff to Systems Biology: The Role of Inflammation and Phagocytic Cells in Cancer”. The symposium will address recent advances in the field and should be an exciting forum for discussion and debate on the current understanding of cancer and inflammation. Sessions will include: hematopoiesis and phagocytic cell functional regulation, lessons for cancer biology; myeloid cells in cancer; metabolism in immunity and cancer, and promising immune therapies. See the program at Please consider registering in advance.

Tuesday, October 18, 2016, 9:00 am to 4:30 pm

Auditorium (Room 620/630), Bldg 35 

The call-for-abstracts deadline for The Symposium on Cancer Health Disparities is September 30. See for more information.

About the symposium: Not all segments of the U.S. population have equally benefited from the advances in our knowledge and treatment of cancer. As a result, minority, immigrant, and financially disadvantaged populations continue to experience an excessive cancer burden due to barriers in access to health care, cultural barriers, and exposure to carcinogens and pathogens. The causes of these disparities are clearly multifaceted, and may include tumor biological and genetic factors, and their interaction with the environment. This symposium will present recent advances in our understanding of the causes of cancer health disparities, including financial toxicity, lifestyle factors, microbiome, and ancestry, by highlighting various cancer sites, and will discuss disparities in cancer outcome and survivorship, and strategies to reduce these disparities.